| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
3e-18 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
1e-15 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
7e-15 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-14 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-14 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-13 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
8e-13 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
5e-11 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-10 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-10 |